See today's BioWorld Science
To read the full story, subscribe or sign in.
Cancer

CD5-knockout anti-CD5 CAR T-cell product evaluated for relapsed and refractory CD5+ nodal T-cell lymphomas

Jan. 12, 2023
The relative 5-year survival for Non-Hodgkin...
BioWorld Science Conferences CAR T Cancer CAR T